Abbreviations
=============

ARF

:   ADP-ribosylation factor

ARL

:   ARF-like

MAP

:   methionine aminopeptidase

NMT

:   N-myristoyltransferase

ORF

:   open reading frame

 {#s0001}

This article is intended to inform researchers about a collection of ∼200 plasmids recently made available through Addgene ([www.addgene.com](www.addgene.com)), that were generated to facilitate the study of human ARF family GTPases, including all 5 ARF and 2 SAR and an incomplete collection of ARF-like (ARL) proteins. They fall into 3 groups based upon usage; (1) ARF family GTPase expression in mammalian or bacterial cells, (2) N-myristoyltransferase co-expression in bacteria, and (3) pSUPER-based plasmids for siRNA knockdown of human ARF1, ARF3, ARF4, or ARF5. The majority of these plasmids direct the expression of human ARF family GTPases for study in mammalian cells or for purification from bacteria. The constructs are untagged or carry a few commonly used tags such as GFP, HA epitope, or V5-His6. These plasmids were engineered in the Gateway cloning system (Life Technologies) to allow ready insertion of other tags, thus the entry vectors are also provided. A group of 4 plasmids that direct expression of human N-myristoyltransferases, designed for co-expression in bacteria to allow N-myristoylation of recombinant proteins.[@cit0001] is included. We also provide a series of pSUPER-based plasmids.[@cit0003] proven useful in knockdown of ARF1-ARF5 in human cells.[@cit0004] A detailed summary of the construction of these plasmids and examples of their use is provided below and can be found in the cited references. Because ARF proteins in particular are very highly conserved (100% amino acid identity among several mammals including rodents), yet differ in DNA sequence, some of these plasmids may be useful in rescue experiments using gene deletion or knockdown.

Arf Family GTPases in Gateway Vectors for Expression of Arf, Arl, And Sar Proteins in Mammalian and Bacterial Cells {#s0002}
===================================================================================================================

With a long-term goal of studying the human ARF family and their functions in cells, we generated a collection of plasmids that direct expression of 21 different members of the human ARF family. The human ARF family today is known to include as many as 30 different members (Jeremy Wideman, Joel Dacks, and R. A. Kahn; manuscript in preparation). We obtained EST clones from public resources that included the entire open reading frames of ARF1, ARF3--6, ARL1--3, ARL4A/C/D, ARL5A/B, ARL6, ARL8A/B, ARL11, ARL14, ARFRP1, and SAR1A/B. These ORFs were amplified by PCR to add appropriate sites for recombination and insertion into the Gateway entry vector pDONR221. Two entry vectors were created for each ORF, one with and another without stop codons, to allow the generation of untagged or C-terminal tagged proteins. Each of these 42 entry vectors were sequence verified. We note in a few instances (ARL4D, ARL11, ARL14) single bp differences from the current NCBI entries, resulting in single missense mutations, but in each case our sequences were present in the EST clones from which they derived.

This set of 21 ARF family members were used to generate a total of 168 Gateway-derived plasmids, including the 2 sets of entry vectors (with and without stop codons), 4 sets for mammalian cell expression (untagged, or tagged at the C-terminus with HA, V5-His6, or GFP), and 2 sets for expression in bacteria (untagged or tagged at the C-terminus with V5-His6). The names and uses of these plasmids, along with gene names, aliases and NCBI Gene ID numbers are summarized in [**Table 1**](#t0001){ref-type="table"}. Entry clones *with stop codons* were moved into pDEST47 or pDEST14 to generate plasmids for expression of untagged proteins in mammalian or bacterial cells, respectively. Entry clones *lacking a stop codon* were moved into (A) pDSHA, for expression of C-terminal HA tagged proteins in mammalian cells, (B) pDEST47, for expression of C-terminal GFP tagged proteins in mammalian cells, (C) pDEST40, for expression in mammalian cells of C-terminal V5-His6 tagged proteins, and (D) pET-DEST42, for expression in bacteria of C-terminal V5-His6 tagged proteins. Table 1.Summary of the plasmids directing expression of human ARF family GTPases (ARF/ARL/SAR) in mammalian cells or bacteria, using the Gateway cloning system. The GTPase is listed, along with pseudonyms, NCBI Gene ID number, name of the plasmid as it appears in the Addgene collection, short description of the intended use, and reference in which it was first reported. Smaller collections of plasmids used for co-expression in bacteria of proteins of interest with N-myristoyltransferases 1 or 2 (NMT1/2) with or without methionine amino peptidase (MAP). The collection of pSUPER based plasmids directing expression of short hairpin RNAs (shRNAs) that deplete cells of human ARF1--5 are also includedGTPasePseudonymsGene IDAddgene plasmid nameDescriptionUseARF1 375pDONR221-ARF1Entry vector: ARF1 w/ stop codonGateway entry vector   pDONR221-ARF1-no stopEntry vector: ARF1 w/o stop codonGateway entry vector   pDSHA-ARF1-HAARF1-HAMammalian expression   pDEST14-ARF1ARF1Bacterial expression   pDEST47-ARF1-GFPARF1-GFPMammalian expression   pET-DEST42-ARF1-V5-His6ARF1-V5-His6Bacterial expression   pDEST40-ARF1-V5-His6ARF1-V5-His6Mammalian expression   pDEST47-ARF1ARF1Mammalian expressionARF3 377pDONR221-ARF3Entry vector: ARF3 w/ stop codonGateway entry vector   pDONR221-ARF3-no stopEntry vector: ARF3 w/o stop codonGateway entry vector   pDSHA-ARF3-HAARF3-HAMammalian expression   pDEST14-ARF3ARF3Bacterial expression   pDEST47-ARF3-GFPARF3-GFPMammalian expression   pET-DEST42-ARF3-V5-His6ARF3-V5-His6Bacterial expression   pDEST40-ARF3-V5-His6ARF3-V5-His6Mammalian expression   pDEST47-ARF3ARF3Mammalian expressionARF4ARF2378pDONR221-ARF4Entry vector: ARF4 w/ stop codonGateway entry vector   pDONR221-ARF4-no stopEntry vector: ARF4 w/o stop codonGateway entry vector   pDSHA-ARF4-HAARF4-HAMammalian expression   pDEST14-ARF4ARF4Bacterial expression   pDEST47-ARF4-GFPARF4-GFPMammalian expression   pET-DEST42-ARF4-V5-His6ARF4-V5-His6Bacterial expression   pDEST40-ARF4-V5-His6ARF4-V5-His6Mammalian expression   pDEST47-ARF4ARF4Mammalian expressionARF5 381pDONR221-ARF5Entry vector: ARF5 w/ stop codonGateway entry vector   pDONR221-ARF5-no stopEntry vector: ARF5 w/o stop codonGateway entry vector   pDSHA-ARF5-HAARF5-HAMammalian expression   pDEST14-ARF5ARF5Bacterial expression   pDEST47-ARF3-GFPARF5-GFPMammalian expression   pET-DEST42-ARF5-V5-His6ARF5-V5-His6Bacterial expression   pDEST40-ARF5-V5-His6ARF5-V5-His6Mammalian expression   pDEST47-ARF5ARF5Mammalian expressionARF6 382pDONR221-ARF6Entry vector: ARF6 w/ stop codonGateway entry vector   pDONR221-ARF6-no stopEntry vector: ARF6 w/o stop codonGateway entry vector   pDSHA-ARF6-HAARF6-HAMammalian expression   pDEST14-ARF6ARF6Bacterial expression   pDEST47-ARF4-GFPARF6-GFPMammalian expression   pET-DEST42-ARF6-V5-His6ARF6-V5-His6Bacterial expression   pDEST40-ARF6-V5-His6ARF6-V5-His6Mammalian expression   pDEST47-ARF6ARF6Mammalian expressionARL1ARF1L400pDONR221-ARL1Entry vector: ARL1 w/ stop codonGateway entry vector   pDONR221-ARL1-no stopEntry vector: ARL1 w/o stop codonGateway entry vector   pDSHA-ARL1-HAARL1-HAMammalian expression   pDEST14-ARL1ARL1Bacterial expression   pDEST47-ARL1-GFPARL1-GFPMammalian expression   pET-DEST42-ARL1-V5-His6ARL1-V5-His6Bacterial expression   pDEST40-ARL1-V5-His6ARL1-V5-His6Mammalian expression   pDEST47-ARL1ARL1Mammalian expressionARL2ARFL2402pDONR221-ARL2Entry vector: ARL2 w/ stop codonGateway entry vector   pDONR221-ARL2-no stopEntry vector: ARL2 w/o stop codonGateway entry vector   pDSHA-ARL2-HAARL2-HAMammalian expression   pDEST14-ARL2ARL2Bacterial expression   pDEST47-ARL2-GFPARL2-GFPMammalian expression   pET-DEST42-ARL2-V5-His6ARL2-V5-His6Bacterial expression   pDEST40-ARL2-V5-His6ARL2-V5-His6Mammalian expression   pDEST47-ARL2ARL2Mammalian expression   pDEST17-HA-ARL2HA-ARL2Mammalian expressionARL3ARFL3403pDONR221-ARL3Entry vector: ARL3 w/ stop codonGateway entry vector   pDONR221-ARL3-no stopEntry vector: ARL3 w/o stop codonGateway entry vector   pDSHA-ARL3-HAARL3-HAMammalian expression   pDEST14-ARL3ARL3Bacterial expression   pDEST47-ARL3-GFPARL3-GFPMammalian expression   pET-DEST42-ARL3-V5-His6ARL3-V5-His6Bacterial expression   pDEST40-ARL3-V5-His6ARL3-V5-His6Mammalian expression   pDEST47-ARL3ARL3Mammalian expressionARL4AARL410124pDONR221-ARL4AEntry vector: ARL4A w/ stop codonGateway entry vector   pDONR221-ARL4A-no stopEntry vector: ARL4A w/o stop codonGateway entry vector   pDSHA-ARL4A-HAARL4A-HAMammalian expression   pDEST14-ARL4AARL4ABacterial expression   pDEST47-ARL4A-GFPARL4A-GFPMammalian expression   pET-DEST42-ARL4A-V5-His6ARL4A-V5-His6Bacterial expression   pDEST40-ARL4A-V5-His6ARL4A-V5-His6Mammalian expression   pDEST47-ARL4A-GFPARL4AMammalian expressionARL4CARL7, LAK10123pDONR221-ARL4CEntry vector: ARL4C w/ stop codonGateway entry vector   pDONR221-ARL4C-no stopEntry vector: ARL4C w/o stop codonGateway entry vector   pDSHA-ARL4C-HAARL4C-HAMammalian expression   pDEST14-ARL4CARL4CBacterial expression   pDEST47-ARL4C-GFPARL4C-GFPMammalian expression   pET-DEST42-ARL4C-V5-His6ARL4C-V5-His6Bacterial expression   pDEST40-ARL4C-V5-His6ARL4C-V5-His6Mammalian expression   pDEST47-ARL4CARL4CMammalian expressionARL4DARL9, ARL4L379pDONR221-ARL4DEntry vector: ARL4D w/ stop codonGateway entry vector   pDONR221-ARL4D-no stopEntry vector: ARL4D w/o stop codonGateway entry vector   pDSHA-ARL4D-HAARL4D-HAMammalian expression   pDEST14-ARL4DARL4DBacterial expression   pDEST47-ARL4D-GFPARL4D-GFPMammalian expression   pET-DEST42-ARL4D-V5-His6ARL4D-V5-His6Bacterial expression   pDEST40-ARL4D-V5-His6ARL4D-V5-His6Mammalian expression   pDEST47-ARL4DARL4DMammalian expressionARL5AARL5, ARFLP526225pDONR221-ARL5AEntry vector: ARL5A w/ stop codonGateway entry vector   pDONR221-ARL5A-no stopEntry vector: ARL5A w/o stop codonGateway entry vector   pDSHA-ARL5A-HAARL5A-HAMammalian expression   pDEST14-ARL5AARL5ABacterial expression   pDEST47-ARL5A-GFPARL5A-GFPMammalian expression   pET-DEST42-ARL5A-V5-His6ARL5A-V5-His6Bacterial expression   pDEST40-ARL5A-V5-His6ARL5A-V5-His6Mammalian expression   pDEST47-ARL5AARL5AMammalian expressionARL5BARL8221079pDONR221-ARL5BEntry vector: ARL5B w/ stop codonGateway entry vector   pDONR221-ARL5B-no stopEntry vector: ARL5B w/o stop codonGateway entry vector   pDSHA-ARL5B-HAARL5B-HAMammalian expression   pDEST14-ARL5BARL5BBacterial expression   pDEST47-ARL5B-GFPARL5B-GFPMammalian expression   pET-DEST42-ARL5B-V5-His6ARL5B-V5-His6Bacterial expression   pDEST40-ARL5B-V5-His6ARL5B-V5-His6Mammalian expression   pDEST47-ARL5BARL5BMammalian expressionARL6BBS3, RP5584100pDONR221-ARL6Entry vector: ARL6 w/ stop codonGateway entry vector   pDONR221-ARL6-no stopEntry vector: ARL6 w/o stop codonGateway entry vector   pDSHA-ARL6-HAARL6-HAMammalian expression   pDEST14-ARL6ARL6Bacterial expression   pDEST47-ARL6-GFPARL6-GFPMammalian expression   pET-DEST42-ARL6-V5-His6ARL6-V5-His6Bacterial expression   pDEST40-ARL6-V5-His6ARL6-V5-His6Mammalian expression   pDEST47-ARL6ARL6Mammalian expressionARL8AGIE2, ARL10B127829pDONR221-ARL8AEntry vector: ARL8A w/ stop codonGateway entry vector   pDONR221-ARL8A-no stopEntry vector: ARL8A w/o stop codonGateway entry vector   pDSHA-ARL8A-HAARL8A-HAMammalian expression   pDEST14-ARL8AARL8ABacterial expression   pDEST47-ARL8A-GFPARL8A-GFPMammalian expression   pET-DEST42-ARL8A-V5-His6ARL8A-V5-His6Bacterial expression   pDEST40-ARL8A-V5-His6ARL8A-V5-His6Mammalian expression   pDEST47-ARL8AARL8AMammalian expressionARL8BGIE1, ARL10C55207pDONR221-ARL8BEntry vector: ARL8B w/ stop codonGateway entry vector   pDONR221-ARL8B-no stopEntry vector: ARL8B w/o stop codonGateway entry vector   pDSHA-ARL8B-HAARL8B-HAMammalian expression   pDEST14-ARL8BARL8BBacterial expression   pDEST47-ARL8B-GFPARL8B-GFPMammalian expression   pET-DEST42-ARL8B-V5-His6ARL8B-V5-His6Bacterial expression   pDEST40-ARL8B-V5-His6ARL8B-V5-His6Mammalian expression   pDEST47-ARL8BARL8BMammalian expressionARL11ARLTS1115761pDONR221-ARL11Entry vector: ARL11 w/ stop codonGateway entry vector   pDONR221-ARL11-no stopEntry vector: ARL11 w/o stop codonGateway entry vector   pDSHA-ARL11-HAARL11-HAMammalian expression   pDEST14-ARL11ARL11Bacterial expression   pDEST47-ARL11-GFPARL11-GFPMammalian expression   pET-DEST42-ARL11-V5-His6ARL11-V5-His6Bacterial expression   pDEST40-ARL11-V5-His6ARL11-V5-His6Mammalian expression   pDEST47-ARL11ARL11Mammalian expressionARL14ARF7, ARL1080117pDONR221-ARL14Entry vector: ARL14 w/ stop codonGateway entry vector   pDONR221-ARL14-no stopEntry vector: ARL14 w/o stop codonGateway entry vector   pDSHA-ARL14-HAARL14-HAMammalian expression   pDEST14-ARL14ARL14Bacterial expression   pDEST47-ARL14-GFPARL14-GFPMammalian expression   pET-DEST42-ARL14-V5-His6ARL14-V5-His6Bacterial expression   pDEST40-ARL14-V5-His6ARL14-V5-His6Mammalian expression   pDEST47-ARL14ARL14Mammalian expressionARFRP1ARP, ARP1, ARL1810139pDONR221-ARFRP1Entry vector: ARFRP1 w/ stop codonGateway entry vector   pDONR221-ARFRP1-no stopEntry vector: ARFRP1 w/o stop codonGateway entry vector   pDSHA-ARFRP1-HAARFRP1-HAMammalian expression   pDEST14-ARFRP1ARFRP1Bacterial expression   pDEST47-ARFRP1-GFPARFRP1-GFPMammalian expression   pET-DEST42-ARFRP1-V5-His6ARFRP1-V5-His6Bacterial expression   pDEST40-ARFRP1-V5-His6ARFRP1-V5-His6Mammalian expression   pDEST47-ARFRP1ARFRP1Mammalian expressionSAR1ASAR1, Sara, SARA1, masra256681pDONR221-SAR1AEntry vector: SAR1A w/ stop codonGateway entry vector   pDONR221-SAR1A-no stopEntry vector: SAR1A w/o stop codonGateway entry vector   pDSHA-SAR1A-HASAR1A-HAMammalian expression   pDEST14-SAR1ASAR1ABacterial expression   pDEST47-SAR1A-GFPSAR1A-GFPMammalian expression   pET-DEST42-SAR1A-V5-His6SAR1A-V5-His6Bacterial expression   pDEST40-SAR1A-V5-His6SAR1A-V5-His6Mammalian expression   pDEST47-SAR1ASAR1AMammalian expressionSAR1BANDD, CMRD, GTBPB, SARA251128pDONR221-SAR1BEntry vector: SAR1B w/ stop codonGateway entry vector   pDONR221-SAR1B-no stopEntry vector: SAR1B w/o stop codonGateway entry vector   pDSHA-SAR1B-HASAR1B-HAMammalian expression   pDEST14-SAR1BSAR1BBacterial expression   pDEST47-SAR1B-GFPSAR1B-GFPMammalian expression   pET-DEST42-SAR1B-V5-His6SAR1B-V5-His6Bacterial expression   pDEST40-SAR1B-V5-His6SAR1B-V5-His6Mammalian expression   pDEST47-SAR1BSAR1BMammalian expressionNMT1  pMON-HsNMT1NMT1Bacterial co-expressionNMT2  pMON-HsNMT2NMT2Bacterial co-expressionNMT1 + Met AP  pMON-NMT1+MAPNMT1 + MAPBacterial co-expressionNMT2 + MetAP  pMON-NMT2+MAPNMT2 + MAPBacterial co-expressionHsARF1 shRNA  pSUPER-ARF1aARF1 shRNAKnockdown in human cellsHsARF1 shRNA  pSUPER-ARF1bARF1 shRNAKnockdown in human cellsHsARF3 shRNA  pSUPER-ARF3aARF3 shRNAKnockdown in human cellsHsARF3 shRNA  pSUPER-ARF3bARF3 shRNAKnockdown in human cellsHsARF4 shRNA  pSUPER-ARF4aARF4 shRNAKnockdown in human cellsHsARF4 shRNA  pSUPER-ARF4bARF4 shRNAKnockdown in human cellsHsARF5 shRNA  pSUPER-ARF5aARF5 shRNAKnockdown in human cellsHsARF5 shRNA  pSUPER-ARF5bARF5 shRNAKnockdown in human cells

We chose not to tag the N-terminus because at least some, perhaps all, ARF family GTPases use the N-terminus as a nucleotide and phospholipid sensitive switch.[@cit0005] that may be directly involved in binding to effectors (e.g., see Zhang, et al).[@cit0006] In addition, co- or post-translational modifications of the N-termini, including N-myristoylation of ARFs.[@cit0007] and ARL1.[@cit0010] and acetylation of ARL3 and ARL8s,[@cit0014] have been found to be essential for cellular functions. The one exception to the use of N-terminal fusions is HA-ARL2, as we have found this N-terminal extension inhibits mitochondrial import and facilitates resolution of cytosolic and mitochondrial effects of ARL2 (Laura Newman, Cara Schiavon, Richard A. Kahn; manuscript in preparation). Concerns over the use of C-terminal fusions of ARF family members have been reported,[@cit0017] and users of these constructs are advised to include whatever controls are possible to protect against artifacts resulting from protein over-expression and/or interference by the tag in protein-protein interactions and functions. Finally, members of the Kahn laboratory have used most of these plasmids over the past few years for a variety of purposes. Our data suggest that the HA tagged proteins express quite poorly and more variably so preference should be given to the GFP or V5-His6 versions before using the HA-tagged constructs. The problem may lie in the vector backbone as we have expressed HA-tagged ARF proteins from pCDNA3-based vectors without this problem.

Vectors for Co-Expression of N-Myristoyltransferase (NMT) With or Without Methionine Aminopeptidase (MAP) in Bacteria {#s0003}
=====================================================================================================================

N-myristoylation is the co-translational, covalent attachment of the saturated 14-carbon fatty acid myristate onto the N-terminal glycine of certain proteins, after cleavage of the initiating methionine.[@cit0018] Not all proteins with N-terminal glycines are N-myristoylated (e.g.,, ARL2 is not) yet many of those that are require the modification for function in cells.[@cit0005] ARFs use the N-myristate as a critical part of its nucleotide-dependent, and therefore reversible, membrane association mechanism. N-myristoylation of exogenously expressed proteins in mammalian cells is an efficient process; the proteins are completely acylated and the acyl group is thought to persist through the lifetime of the protein.[@cit0018] However, bacteria do not express NMTs and have relatively small pools of myristoyl coA (the other substrate of NMTs). Thus, to generate recombinant, N-myristoylated proteins in bacteria, it is necessary to co-express an NMT with the ARF/ARL protein of interest. Such a system was devised by Duronio, et al,[@cit0001] and allows dual selection of the NMT carrying plasmid with kanamycin and the selection of the NMT substrate (e.g., ARF1) with ampicillin. The use of different bacterial promoters also allows for independent induction of the NMT and the ARF/ARL substrate. Some NMT substrates can be purified from bacteria in a nearly completely acylated state by the use of this system. In contrast, we have found that human ARFs are incompletely (as low as a few %) N-myristoylated, resulting in a mixture of acylated and unmodified proteins that can be difficult to resolve. Among the approaches tried in our lab to increase the yield of the acylated species was the co-expression of methionine aminopeptidase (MAP) with the NMT, with the idea that more rapid or complete cleavage of the initiating methionine may result in higher stoichiometry of myristoylation. While we found this to be true, the effects were not as large as hoped.[@cit0002] Anyone using bacteria for expression of N-myristoylated proteins should be aware that incomplete acylation is common, though this is highly dependent on the substrate and the NMT used.

Plasmids were generated that direct expression of either human NMT1 or NMT2 and each construct was made with or without the ability to co-express the bacterial MAP, as described in detail in Van Valkenburgh, et al.[@cit0002] These 4 plasmids are listed in [**Table 1**](#t0001){ref-type="table"}. Note that the plasmids in this collection are for expression/co-expression of human NMTs, while the original work from the Gordon lab used the yeast ortholog.[@cit0001] Some differences in specificity and efficiency of N-myristoylation in bacterial co-expression systems have been described.[@cit0002] While the Gordon lab has done an outstanding job of characterizing substrate specificities of NMTs for their substrates,[@cit0024] we recommend empirical testing of the best NMT. The value of co-expressing MAP should also be empirically determined, though we have observed no negative consequences due to MAP co-expression.

psuper-BASED PLASMIDS for SIRNA KNOCKDOWN of HUMAN ARF1, ARF3, ARF4, OR ARF5 {#s0004}
============================================================================

Brummelkamp, et al.[@cit0003] developed the pSUPER vector for use in generating short interfering RNAs to knockdown expression of specific proteins in mammalian cells. This reference includes clear directions for the generation of plasmids that drive expression off the polymerase III H1-RNA promoter to generate 19nt of double stranded RNA with a hairpin that suppresses expression of genes of interest. We designed into the pSUPER vector 5 different targets directed toward human ARF1, ARF3, ARF4, or ARF5, and examined their effectiveness in depleting cells of specific ARFs. The two best for each ARF were then used in studies examining the consequences of single or dual knockdowns, as described in Volpicelli-Daley, et al.[@cit0004] The use of at least 2 sequence-independent targets was used to decrease chances of off-target effects being responsible for the observed phenotypes. The use of synthetic RNAs and more recently of the CRISPR/CAS9 technology appears to have superseded the use of plasmid-based siRNA, but the availability of verified plasmids for knockdown of human ARFs allows the generation of stably transfected cell lines in which the level of each ARF can be experimentally modulated. While the Kahn lab was the source for rabbit polyclonal antibodies specific to each of the human ARF proteins.[@cit0027] for many years that were useful in detecting and quantifying knockdowns, unfortunately these reagents are no longer available to the public as a result of depletion in stocks of rabbit sera.
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